Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Stroke ; 35(5): e109-11, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15087568

RESUMEN

BACKGROUND AND PURPOSE: We present our single-center experience using catheter-based therapy for acute ischemic stroke patients who were not candidates for intravenous thrombolytic therapy. METHODS: Neurologic outcomes were assessed in patients with acute ischemic stroke, ineligible for intravenous thrombolysis, treated with an emergent catheter-based therapy. RESULTS: Nonparametric analysis of neurological outcomes demonstrated a benefit in National Institutes of Health Stroke Scale (NIHSS) at long-term follow-up (P=0.036). Independence in daily activities and improvement in NIHSS of > or =4 points were achieved in 38% and 56% of patients, respectively. Four patients (25%) died, including 2 patients (12.5%) who died from intracranial hemorrhage. CONCLUSIONS: Catheter-based treatment offers a promising treatment strategy in patients with acute ischemic stroke ineligible for intravenous thrombolysis.


Asunto(s)
Angioplastia de Balón/métodos , Isquemia Encefálica/tratamiento farmacológico , Isquemia Encefálica/terapia , Accidente Cerebrovascular/tratamiento farmacológico , Accidente Cerebrovascular/terapia , Terapia Trombolítica/métodos , Anciano , Isquemia Encefálica/diagnóstico , Femenino , Heparina/administración & dosificación , Heparina/uso terapéutico , Humanos , Infarto de la Arteria Cerebral Media/prevención & control , Infusiones Intraarteriales , Hemorragias Intracraneales/prevención & control , Masculino , Índice de Severidad de la Enfermedad , Estadísticas no Paramétricas , Stents , Accidente Cerebrovascular/diagnóstico , Activador de Tejido Plasminógeno/uso terapéutico , Resultado del Tratamiento , Activador de Plasminógeno de Tipo Uroquinasa/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA